System Validation ALPHA II · INVENIO · LUMOS II

Significance of the Topic

FT-IR spectroscopy is a cornerstone analytical technique in pharmaceutical development and quality control, supporting molecular fingerprinting and material verification under strict regulatory frameworks. System validation ensures reliable, traceable results in compliance with GMP, GLP and cGMP standards.

Objectives and Study Overview

This document outlines the comprehensive validation strategy for Bruker’s ALPHA II, INVENIO FT-IR spectrometers and LUMOS II microscope. It covers requirements from design qualification through performance qualification, aiming to streamline compliance and documentation for pharmaceutical laboratories.

Methodology and Instrumentation

The validation approach employs fully automated test routines integrated in the OPUS software suite, leveraging a certified polystyrene reference standard. Key steps include design qualification (DQ), installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ). Validation packages (S010/x, S020/x, S030/M) support protocol-driven execution and reporting.

Main Results and Discussion

Automated routines provide non-editable test reports, continuous monitoring of validation status, and quick performance checks at startup and upon accessory changes. Active Directory authentication, audit trails, and single-file data storage ensure traceability and integrity. The LUMOS II’s FPA imaging complies with European Pharmacopoeia 5.24, using PermaSure+ technology to maintain spectral accuracy.

Benefits and Practical Applications of the Method

• Accelerated compliance through automated OQ/PQ testing tailored to pharmacopeia standards (PhEur, PhJP, USP).
• Reduced validation costs by involving factory-trained service engineers for system installation and annual certification.
• Secure data handling with 21 CFR Part 11 compliance, electronic signatures and audit trails.

Future Trends and Opportunities

Advancements may include cloud-based validation monitoring, AI-driven data analysis, integration with laboratory information management systems and expansion of automated protocols to additional spectroscopic modalities.

Conclusion

Bruker’s system validation framework for FT-IR instruments offers a robust, automated solution for pharmaceutical compliance, combining certified standards, validated software and service support to ensure data integrity and regulatory adherence.

References

• European Pharmacopoeia 2.2.24 and 5.24, Japanese Pharmacopoeia 2.25, USP <854>
• Title 21 CFR Part 11, FDA
• Patents: US 7034944; DE 19940981